Seventure goes with its gut for funding focus
This article was originally published in Clinica
With a rapid increase of research into the human microbiome, Seventure continues to attract investors into its Health for Life Capital Fund. Since launching the fund in December 2013, Seventure has raised a total of €100m ($105m) to back microbiome-focused businesses in the pharmaceutical and nutrition sectors. The latest €25m tranche edges the French venture capitalist closer to its €120m target.